Funding Communiqué


May 17th, 2016 (Ottawa) The Stem Cell Network (SCN) is pleased to launch three new funding competitions to support high-quality translational research in stem cell and regenerative medicine research.

In March 2016 the federal government demonstrated its support for SCN and Canadian stem cell research with an investment of $12 million over two years. SCN is now moving quickly to ensure these new research funding dollars are put to work across Canada as soon as possible.

“Canada has considerable scientific strength in stem cell research and regenerative medicine; over the past 15 years the Stem Cell Network has played a central role in supporting and training the most promising researchers from across the country,” said Dr. Michael Rudnicki, Scientific Director. “The funding programs we are launching today will help ensure that innovative ideas translate into the therapeutics and treatments of tomorrow.”

The three key funding programs are:

Impact Research Agreements: Eligible projects will fall under one of three categories: clinical translation, commercialization or public policy. These projects are best suited to research that is ready to move down a translational path, or will support the development of evidence-based policies and practices.

Disease Team Research Agreements: Eligible projects will bring together multiple investigators with different expertise who will collaborate on initiatives that are developing novel cellular or stem cell-related therapeutic approaches to tissue repair and regeneration for specific diseases. Examples of such diseases include, but are not restricted to, diabetes, heart disease, septic shock and lung disease.

Clinical Trial Research Agreements: Eligible projects will be phase 1 or 2 clinical trials and have received Health Canada approval. It is expected that successful projects will show incremental benefit to the patient, as well as provide an economic analysis of the potential cost of treatment compared to current best-available standard of care.

Philip Welford, Executive Director of SCN, noted, “Today marks the start of another important chapter for our research community and SCN is thrilled to once again be able to offer research funding programs that will truly move the science from bench to bedside.”

Call for Proposals for the Impact Research Agreements Program will be open until June 15th.  Those applying for funding under the disease team or clinical trials programs are required to submit a letter of intent by end of day on June 15th. All proposals will be peer reviewed and results of the competitions will be announced by the end of 2016. Funding is dependent on the completion of SCN’s federal contribution agreement for 2016-18.  More information can be found here .


Established in 2001, the Stem Cell Network (SCN) has become Canada’s foremost research organization dedicated to enabling the translation of stem cell research into clinical applications, commercial products and public policy. SCN is co-hosted by the Ottawa Hospital Research Institute and the University of Ottawa. SCN is proud to partner with Centre for Commercialization of Regenerative Medicine & the Ontario Institute of Regenerative Medicine on the annual Till & McCulloch Conference, Canada’s premier stem cell research event. For more information about SCN please visit

Cate Murray
Director, Communications & External Relations